Search results for "OTHER"

showing 10 items of 12132 documents

Rituximab in Combination with CHOP in Patients with Follicular Lymphoma: Analysis of Treatment Outcome of 552 Patients Treated in a Randomized Trial …

2008

Abstract We have previously reported that compared to CHOP alone the addition of Rituximab (R) to CHOP significantly increases the response rate (RR), the time to treatment failure (TTF) and also the overall survival (OS) in patients with newly diagnosed advanced follicular lymphoma. However, in the previous report, the median observation time was short with 18 months and no data were reported on the outcome of different risk groups according to the FLIPI (Hiddemann et al., Blood 2005). We now report on the treatment outcome of 552 patients with advanced stage follicular lymphoma randomized between R-CHOP versus CHOP alone after a median follow up of 58 months. Responding patients < …

medicine.medical_specialtybusiness.industryImmunologyFollicular lymphomaAlpha interferonCell BiologyHematologyCHOPDebulkingmedicine.diseaseBiochemistryChemotherapy regimenGastroenterologySurgerylaw.inventionRandomized controlled trialMedian follow-uplawInternal medicinemedicineRituximabbusinessmedicine.drugBlood
researchProduct

Intensification therapy with golimumab: a new treatment strategy for moderate-severe refractory psoriasis

2014

medicine.medical_specialtybusiness.industryMEDLINEArthritisDermatologymedicine.diseaseGolimumabPharmacotherapyRefractoryPsoriasisInternal medicineSeverity of illnessmedicinePhysical therapybusinessmedicine.drugIntensification therapyInternational Journal of Dermatology
researchProduct

Effect Of Preoperative Respiratory Physiotherapy Program On The Oxygenation In Obese Morbid Patients Undergoing Laparoscopic Bariatric Surgery

2012

medicine.medical_specialtybusiness.industryMedicineOxygenationRespiratory physiotherapybusinessSurgeryC65. PERIPHERAL MUSCLE DYSFUNCTION
researchProduct

Symptomatic and Ancillary Therapy

2010

Although enzyme replacement therapy has had a considerable impact on the management of patients with Fabry disease, it is essential that attention is also given to supportive therapy. In this chapter a general overview about ancillary therapy is given. The great variability of clinical symptoms faced by patients with Fabry disease need the involvement from many different specialists, as well as a wide range of concomitant treatments. Coordinating a good multidisciplinary approach for each patient and ensuring that treatment is made as convenient as possible may offer a more positive impact on the quality of life of those patients affected by Fabry disease.

medicine.medical_specialtybusiness.industryMultidisciplinary approachSupportive psychotherapyConcomitantmedicineEnzyme replacement therapyIntensive care medicinebusinessmedicine.diseaseFabry disease
researchProduct

Phase IA/II Study of Oral LBH589, a Novel Deacetylase Inhibitor (DACi), Administered on 2 Schedules, in Patients with Advanced Hematologic Malignanci…

2007

Abstract LBH589 is a novel cinnamic acid hydroxamate DACi which induces apoptosis in multiple hematologic tumor cell lines in vitro at nanomolar levels. LBH589 has been administered orally, once-a-day, on Monday/Wednesday/Friday, every week (Arm 1) or every other week (Arm 2), in cycles of 28 days, to adult pts with advanced hematologic malignancies. A 3-parameter Bayesian logistic regression model guided dose escalation. To date, 61 pts, median age 67 yrs (range 16–87), 40 male, 21 female, have been enrolled: 33 pts in Arm 1 at dose levels (mg/dose) of 20 (9 pts), 30 (12 pts), 40 (10 pts), and 60 (2 pts); 28 pts in Arm 2 at dose levels (mg/dose) of 30 (7 pts), 45 (12 pts), and 60 (9 pts). …

medicine.medical_specialtybusiness.industryNauseaImmunologyPeripheral edemaCell BiologyHematologyNeutropeniamedicine.diseaseBiochemistryGastroenterologySurgeryEvery other weekInternal medicineVomitingmedicineIn patientmedicine.symptombusinessAdverse effectFebrile neutropeniaBlood
researchProduct

The effect of the calibre and length of needle on the stability of sclerosing foam.

2020

Objectives Little is known how calibre and length of needles affect the stability of sclerosing foam. Methods Foams were made of 0.5%, 1%, 2% and 3% polidocanol, and 0.2%, 0.5%, 1% and 3% sodium tetradecyl sulfate (STS), which were mixed with air in the proportion of 4:1. These foams were ejected through needles with the length of: 4 mm, 6 mm and 13 mm, and diameter of: 0.26 mm, 0.3 mm and 0.4 mm. Results Foams made of more concentrated polidocanol were more stable. Regarding STS an opposite relationship was revealed. Foams made of polidocanol were more stable if ejected through a longer needle, while the length of needle did not significantly affect stability of STS foams. Foams ejected th…

medicine.medical_specialtybusiness.industrySodiumPolidocanolchemistry.chemical_elementGeneral Medicine030204 cardiovascular system & hematologyGastroenterologySclerosing SolutionsPolyethylene GlycolsPolidocanolSodium Tetradecyl Sulfate030207 dermatology & venereal diseases03 medical and health sciencesFoam sclerotherapy; adverse events; needles0302 clinical medicinechemistryNeedlesInternal medicineSclerotherapymedicineHumansCardiology and Cardiovascular Medicinebusinessmedicine.drugPhlebology
researchProduct

Different Morning Blood Pressure Increases are Associated to a Diverse Microvascular Damage

2007

medicine.medical_specialtybusiness.industryStiffness indexRenal functionEssential hypertensionmedicine.diseasemedicine.anatomical_structurePharmacotherapyInternal medicineAmbulatoryInternal MedicinemedicineCardiologyCardiology and Cardiovascular MedicinebusinessArteryHigh Blood Pressure & Cardiovascular Prevention
researchProduct

Absorption of drugs from the bladder and intravesical chemotherapy

1976

medicine.medical_specialtybusiness.industryUrologyUrinary BladderUrologyAntineoplastic AgentsPharmaceutical PreparationsUrinary Bladder NeoplasmsInjections IntravenousAnimalsHumansMedicineRabbitsIntravesical chemotherapybusinessAbsorption (electromagnetic radiation)ThiotepaUrological Research
researchProduct

Effect of comprehensive vasodilation vs usual care on mortality and heart failure rehospitalization in women with acute heart failure

2020

Abstract Background Guidelines recommend evaluating the risk/benefit ratio of novel therapies individually in women and men, as the pathophysiology and the response to treatment may differ between women and men. Among patients with acute heart failure (AHF), a strategy of intensive vasodilation, compared with usual care, overall did provide comparable outcomes. Purpose To evaluate the effect of a strategy that emphasized early intensive and sustained vasodilation in women with AHF. Methods In a randomized, open-label blinded-end-point trial patients hospitalized for AHF were enrolled in 10 hospitals in Switzerland, Bulgaria, Germany, Brazil, and Spain. Inclusion criteria were AHF expressed …

medicine.medical_specialtybusiness.industryVasodilationmedicine.diseasePatient roomPharmacotherapyBlood pressurePlasma drug concentrationInternal medicineHeart failureUsual caremedicineCardiologyCardiology and Cardiovascular MedicineAdverse effectbusinessEuropean Heart Journal
researchProduct

[I062] The roles of radiographers in medical imaging and radiotherapy in Europe

2018

Very fast development of technologies in medical imaging and therapy has changed the role of radiographer in Europe. Over the past ten years education and necessary skills and competencies for radiographers has become more similar in most EU countries due to input of EFRS Educational Wing, but there are still rather significant differences in the roles of radiographers between countries. Role expansion is often initiated by external and internal factors that lead to advanced practice for radiographers. However, there is also a limiting factor that functions as a barrier for development of radiographer’s role and mainly that is connected to resistance when radiologists/medical physicists obj…

medicine.medical_specialtybusiness.industrymedia_common.quotation_subjectmedicine.medical_treatmentBiophysicsGeneral Physics and AstronomyGeneral MedicineRadiotherapy treatment planningEu countriesrespiratory tract diseasesRadiation therapyMedical physicistPresentationMedical imagingmedicineRadiology Nuclear Medicine and imagingQuality (business)Medical physicsbusinessmedia_commonPhysica Medica
researchProduct